134 related articles for article (PubMed ID: 11396239)
1. Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopic ultrasonography.
Casella G; Buda CA; Maisano R; Schiavo M; Perego D; Baldini V
Anticancer Res; 2001; 21(2B):1499-502. PubMed ID: 11396239
[TBL] [Abstract][Full Text] [Related]
2. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
[TBL] [Abstract][Full Text] [Related]
3. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
4. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
5. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
[TBL] [Abstract][Full Text] [Related]
6. Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication.
Cammarota G; Fedeli P; Bianchi A; Cianci R; Martino A; Fedeli G; Gasbarrini G
Hepatogastroenterology; 2005; 52(63):975-7. PubMed ID: 15966244
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
[TBL] [Abstract][Full Text] [Related]
8. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.
Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F
Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
12. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
[TBL] [Abstract][Full Text] [Related]
13. [Gastric MALT lymphoma, clinical features].
Udvardy M
Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
[TBL] [Abstract][Full Text] [Related]
14. [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
Sciumè C; Geraci G; Pisello F; Li Volsi F; Facella T; Modica G
Ann Ital Chir; 2004; 75(1):63-8; discussion 69. PubMed ID: 15283390
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe.
Yeh HZ; Chen GH; Chang WD; Poon SK; Yang SS; Lien HC; Chang CS; Chou G
J Gastroenterol Hepatol; 2003 Feb; 18(2):162-7. PubMed ID: 12542600
[TBL] [Abstract][Full Text] [Related]
16. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
17. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
[TBL] [Abstract][Full Text] [Related]
18. [Endoscopic ultrasound (EUS) in initial assessment and follow-up of patients with MALT lymphoma treated drug therapy].
Pavlović AR; Krstić M; Tomić D; Bjelović M; Jesić R; Suvajdzić N
Acta Chir Iugosl; 2005; 52(1):83-9. PubMed ID: 16119319
[TBL] [Abstract][Full Text] [Related]
19. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY
J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795
[TBL] [Abstract][Full Text] [Related]
20. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
